Efficacy of radioactive 125I seed implantation in treating inoperable or refused operation head and neck cancers.
Zhang Y, Liang Y, Liu Z, Zhang H, Gao Z, Wang J.
J Cancer Res Ther. 2024 Apr 1;20(2):642-650. doi: 10.4103/jcrt.jcrt_1891_23. Epub 2024 Apr 30.
PMID:38687935
Radioactive (125)I seed implantation for locally advanced pancreatic cancer: A retrospective analysis of 50 cases.
Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY.
World J Clin Cases. 2020 Sep 6;8(17):3743-3750. doi: 10.12998/wjcc.v8.i17.3743.
PMID:32953850
Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.
Terk MD, Stock RG, Stone NN.
J Urol. 1998 Oct;160(4):1379-82.
PMID:9751358
Evaluation of radioactive (125)I seed implantation for the treatment of refractory malignant tumours based on a CT-guided 3D template-assisted technique: efficacy and safety.
Zhao GS, Liu S, Yang L, Li C, Wang RY, Zhou J, Zhang YW.
BMC Cancer. 2020 Aug 3;20(1):718. doi: 10.1186/s12885-020-07223-3.
PMID:32746784
Experimental validation of the accuracy of robotic-assisted radioactive seed implantation for tumor treatment.
Ji Z, Wang Z, Jiang Y, Sun H, Qiu B, Li C, Liu B, Li Q, Zhang L, Bai X, Wei Y, Li C, Wang R, Wang J.
J Robot Surg. 2024 May 21;18(1):219. doi: 10.1007/s11701-024-01957-z.